中文名称：聚乙丙交酯(50/50)、丙交酯乙交酯共聚物、聚(D,L-乳酸- co-乙醇酸)

英文名称：PLGA(50/50)、poly(D,L-lactic acid-co-glycolic acid)、Poly(D,L-lactide-co-glycolide)

聚（D，L-丙交酯-共-乙交酯）是一种可生物降解的生物相容性聚合物，可用于药物输送。它可用于治疗类风湿性关节炎、溃疡性结肠炎、克罗恩病、炎性肺病、以及眼部炎性疾病。聚（D，L-丙交酯-共-乙交酯）可作为潜在的癌症治疗靶标起作用。
聚（D，L-丙交酯-共-乙交酯）已经用于在凝胶中提高和维持乳酸盐单体水平，其浓度与皮肤伤口有关。
特点和优势在于控释生物活性剂、缝线和可生物吸收植入器件，具有生物相容性且可生物降解的聚合物。

Poly (D, L-lactide co glycolide) is a biodegradable biocompatible polymer, which can be used for drug delivery. It can be used to treat rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammatory lung disease, and ocular inflammatory diseases. Poly (D, L-lactide co glycolide) can act as a potential cancer therapeutic target.

Poly (D, L- lactide co glycolide) has been used to improve and maintain lactate monomer level in gel, and its concentration is related to skin wound.

The characteristics and advantages are controlled-release bioactive agents, sutures and bioabsorbable implant devices, biocompatible and biodegradable polymers.